Neuropsychological Effects of Stimulant Medication on Children’s Learning and Behavior

Brown, Ronald T.; Daly, Brian P.

doi:10.1007/978-0-387-78867-8_22

Cited by 4 publications

(1 citation statement)

References 297 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The therapeutic benefit of stimulant drug therapy has been demonstrated among a number of pediatric populations who have impairments in attention and concentration (for review see, Brown & Daly, 2009), including healthy children with ADHD (Barkley, 1998), children with acquired brain injuries (Waldron-Perrine, Hanks & Perrine, 2008), and children with cancer (Conklin et al, 2007;Thompson et al, 2001). Children with ADHD share several cognitive, behavioral, and neurological similarities with their peers who have HbSS disease.…”

Section: Psychopharmacological Treatmentsmentioning

confidence: 98%

The Role of Neuropsychological Evaluation in Pediatric Sickle Cell Disease

Daly

Kral

Tarazi

2011

The Clinical Neuropsychologist

View full text Add to dashboard Cite

Neuropsychological impairment occurs in children and adolescents with sickle cell disease. While the neuropsychological sequelae associated with cerebrovascular disease in these children have been identified, a well-informed clinical approach to neuropsychological evaluation for these vulnerable children has not been delineated. Moreover, issues related to standard of care for children and adolescents with sickle cell disease and transition to adulthood remain understudied despite the relevance to long-term medical, psychosocial, and neuropsychological outcomes. We provide recommendations for an informed approach to neuropsychological evaluation of youth with sickle cell disease that is determined by pertinent illness-related factors, consideration of general developmental level and timing of evaluation (i.e., baseline vs follow-up evaluation), relationship to medical treatment, and transition to adulthood. Although the neuropsychological methods presented in this manuscript are specific to sickle cell disease, this empirically informed approach may serve as a model for other pediatric populations.

show abstract